U.S. stocks tanked Wednesday, look wobbly Thursday. Meanwhile, a giant wedged-in container ship blocks the Suez canal, halting oil transport.
For those overweight in tech heavy NASDAQ shares, Tuesday began, like Monday, as yet another adventure in investing Hell.
There was some, but not much, excitement among investors Tuesday, as Apple prepared to announce its new products, like a new Apple Watch.
We’re back on the Wall Street roller coaster Tuesday morning. Once again, big tech shares lead the day's sickening decline.
It’s another week and another likely wild ride on Wall Street for US stocks, as tech CEOs face Congress on censorship.
Sector rotation, headline risk will dominate trading action in Q4 2017. Here’s what we’re exploring: Financials, transports, oil companies and target ETFs.
Investors continue to head for the exits in volatile Thursday trading action. It’s not a selling panic – yet – as retail, financials end modestly higher.
Unless you’re in a straight index ETF portfolio, your brokerage account won’t be reaping the positive numbers that TV pundits are crowing about.
Wall Street’s post-Irma, Weird Wednesday action finds averages slightly flat with a negative bias. Home Depot, Valero pop, biopharma secondaries drop.
WASHINGTON, September 5, 2017 – As we’ve noted in our companion column, news of North Korea’s latest blatant act of nuclear one upsmanship has sent U.S. stocks into a swan dive Tuesday. Other market fundamentals, however, are still transfixed by one key question: How quickly all manner of energy companies with business in the Houston-Louisiana ...
The ripple effect stemming from Hurricane Harvey and the massive destruction in and around Houston will strongly influence current and upcoming stock action.
Taking gains in a toppy market is a good idea, although we may get back into some of the fine companies we’ve temporarily chosen to abandon.
Trump Administration's anti-dumping moves against China, Canada, continue to boost Tuesday stocks. Or at least most of them, as housing takes a hit.
WASHINGTON, February 3, 2016 – In all honesty, there’s not a lot of concrete news to report today except for the same old, same old. Oil, commodities and stocks of all shapes and sizes are trading seemingly at random, with prices either overreacting or underreacting to earnings reports, rumors and whatever else the idiots running ...
WASHINGTON, December 28, 2015 – As promised, we’re presenting our extended list of 2016 Bounce Back Stock Candidates. The stocks in our lists have been severely beaten down—rightly or wrongly—in 2015 and for a variety of reasons could experience significant price appreciation in 2016. It’s an almost universally recognized fact that out-of-favor stocks, stocks that ...
WASHINGTON, Dec. 8, 2015 – Today, Tuesday, we are going to split our Market Maven column into two, moving our background market discussions to our other column, The Prudent Man while keeping our specific market recommendations right here. We’re doing this partially to keep column sizes down to an Internet-acceptable minimum—Internet readers seem to really ...
Bloomberg Money Blob tries to engulf Virginia Senate as off-year elections draw the usual low voter turnout. Traders were scarce on Wall Street Tuesday, but the short squeeze continued.
WASHINGTON, Oct. 19, 2015 – Brrr. It’s cold today on the East Coast, as global warming climate change has once again resulted in subfreezing temperatures here rather earlier than normal for October. How allegedly anthropomorphic warming can make us colder and colder every winter is beyond the Maven’s ken. But then again, it must be ...
Pretty much the entire market was taken out back and shot Thursday, as both stocks and averages essentially endured their worst day ever in 2015.
WASHINGTON, July 14, 2015 – Going into the final hour of trading Tuesday, it seems like a fairly decent environment on Wall Street. The problem is, this week’s Era of Good Feelings has a temporary feel about it. Averages continue to go up despite poor U.S. retail sales figures. The allegedly-solved Grexit dilemma is still not ...